These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10396524)

  • 1. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.
    Hart AR; Eaden J; Barnett S; de Bono AM; Mayberry JF
    J Epidemiol Community Health; 1998 Dec; 52(12):818-20. PubMed ID: 10396524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An industry based approach to colorectal cancer screening in an asymptomatic population.
    Hart AR; Glover N; Howick-Baker J; Mayberry JF
    Postgrad Med J; 2003 Nov; 79(937):646-9. PubMed ID: 14654576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.
    Hynam KA; Hart AR; Gay SP; Inglis A; Wicks AC; Mayberry JF
    J Epidemiol Community Health; 1995 Feb; 49(1):84-6. PubMed ID: 7707012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
    Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
    Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance.
    Robinson MH; Pye G; Thomas WM; Hardcastle JD; Mangham CM
    Eur J Surg Oncol; 1994 Oct; 20(5):545-8. PubMed ID: 7926056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
    Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
    Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
    Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for colorectal cancer: a general-practice-based study.
    Marjoram J; Strachan R; Allan A; Allan E
    Br J Gen Pract; 1996 May; 46(406):283-86. PubMed ID: 8762743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of opportunistic screening for occult gastrointestinal blood loss.
    Hobbs FD; Cherry RC; Fielding JW; Pike L; Holder R
    BMJ; 1992 Feb; 304(6825):483-6. PubMed ID: 1547423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
    UK Colorectal Cancer Screening Pilot Group
    BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.